Detalhe da pesquisa
1.
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
Cell
; 176(6): 1265-1281.e24, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827681
2.
Low-frequency inherited complement receptor variants are associated with purpura fulminans.
Blood
; 143(11): 1032-1044, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096369
3.
Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry.
Mod Pathol
; 37(1): 100373, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925056
4.
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Mod Pathol
; 37(1): 100352, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839675
5.
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: Stage 2 of a phase II trial.
Haematologica
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268448
6.
Mechanical checkpoint regulates monocyte differentiation in fibrotic niches.
Nat Mater
; 21(8): 939-950, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817965
7.
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Haematologica
; 108(10): 2730-2742, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165840
8.
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Mod Pathol
; 35(4): 470-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775472
9.
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
J Allergy Clin Immunol
; 147(4): 1497-1501.e1, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248113
10.
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment.
Mod Pathol
; 33(7): 1380-1388, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32051557
11.
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19.
Blood
; 140(18): 1993-1997, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096050
12.
NPM1: not present? Mark!
Blood
; 138(25): 2602-2603, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940821
13.
Beware the "other AML": hepatic angiomyolipoma with extensive extramedullary hematopoiesis.
Blood
; 137(6): 860, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570613
14.
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities.
Haematologica
; 103(4): 626-633, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326119
15.
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome.
Am J Hematol
; 93(4): 504-510, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274134
16.
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
Am J Hematol
; 98(4): E91-E94, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661399
17.
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Mod Pathol
; 35(5): 705, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903824
18.
Marked dysgranulopoiesis mimicking disseminated histoplasmosis.
Blood
; 136(24): 2838, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301038
19.
Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1.
Am J Hematol
; 97(12): E462-E465, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106410
20.
Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib.
Br J Haematol
; 195(3): 466-468, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355802